Wangning Gu
Overview
Explore the profile of Wangning Gu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu H, Fu Y, Tang L, Song B, Gu W, Yang H, et al.
Neoplasia
. 2025 Mar;
62:101142.
PMID: 40081214
Background: Nasopharyngeal carcinoma (NPC) is the most common malignancy of the nasopharynx. Ferroptosis induction shows anti-tumor activities in cancers including NPC. Elucidating the regulatory mechanism of ferroptosis is crucial for...
2.
Liu H, Li Y, Tang L, Sun X, Xie W, Xiao T, et al.
NPJ Precis Oncol
. 2024 Nov;
8(1):252.
PMID: 39501021
Nasopharyngeal carcinoma (NPC) is the most common cancer originating in nasopharynx. Metabolic reprogramming plays a critical role in tumor progression. Exploring mechanisms underlying metabolic reprogramming contributes to deeper understanding of...
3.
Liu Y, Pan R, Ouyang Y, Gu W, Xiao T, Yang H, et al.
Signal Transduct Target Ther
. 2024 Sep;
9(1):245.
PMID: 39300122
Pyroptosis is a type of programmed cell death characterized by cell swelling and osmotic lysis, resulting in cytomembrane rupture and release of immunostimulatory components, which play a role in several...
4.
Zhang H, Li S, Wang D, Liu S, Xiao T, Gu W, et al.
Biomark Res
. 2024 Sep;
12(1):96.
PMID: 39227970
Tumor cells possess complex immune evasion mechanisms to evade immune system attacks, primarily through metabolic reprogramming, which significantly alters the tumor microenvironment (TME) to modulate immune cell functions. When a...
5.
Liu F, Tang L, Liu H, Chen Y, Xiao T, Gu W, et al.
Cell Death Dis
. 2024 Apr;
15(4):279.
PMID: 38637504
Cisplatin (DDP)-based chemoradiotherapy is one of the standard treatments for nasopharyngeal carcinoma (NPC). However, the sensitivity and side effects of DDP to patients remain major obstacles for NPC treatment. This...
6.
Liu H, Tang L, Li Y, Xie W, Zhang L, Tang H, et al.
Mol Cancer
. 2024 Jan;
23(1):20.
PMID: 38254110
The incidence of nasopharyngeal carcinoma (NPC) exhibits significant variations across different ethnic groups and geographical regions, with Southeast Asia and North Africa being endemic areas. Of note, Epstein-Barr virus (EBV)...
7.
Liu H, Tang L, Gong S, Xiao T, Yang H, Gu W, et al.
Cell Death Dis
. 2023 Dec;
14(12):852.
PMID: 38129408
Reprogramming of macrophages toward an M1 phenotype is a novel strategy to induce anticancer immunity. However, the regulatory mechanisms of M1 macrophage polarization and its functional roles in nasopharyngeal carcinoma...
8.
Chen P, Wang D, Xiao T, Gu W, Yang H, Yang M, et al.
Int Immunopharmacol
. 2023 Jul;
122:110629.
PMID: 37451020
Background: Nasopharyngeal carcinoma (NPC) is a head and neck malignant tumor with a high incidence and recurrence rate. The crosstalk between ferroptosis and tumor-associated macrophages (TAMs) is thought to have...
9.
Tang L, Peng L, Liu H, Xiao T, Gu W, Yang H, et al.
Med Oncol
. 2022 Sep;
39(12):214.
PMID: 36175598
Nasopharyngeal carcinoma (NPC) is one of the aggressive malignant tumors with high mortality, and the proliferation of myeloid-derived suppressor cells (MDSCs) could promote the metastasis of NPC through inhibiting the...